2014: Ph.D (Pharmacology, Pharmaceutical Sciences), Singhania University, Rajasthan.

2002: M.Pharm (Pharmacology), College of Pharmaceutical Sciences, Manipal Academy of Higher Education (MAHE), Karnataka

1999: B.Pharm, S.N.Institute of Pharmacy, Amravati University, Maharashtra.

• Invited guest faculty, NIPER, Guwahati to cover the syllabus for Evidence Based Medicine in year 2017.
• Received Financial Assistance for organizing National seminar as Organizing Secretary for Rs 40,000/Rs from ICMR on topic Entitled, “Recent trends in Cancer Research and Management on 20^th September, 2013
• Received Financial Assistance for 50,000/Rs from ICMR & 50,000/Rs from DST for organizing National seminar as organizing secretary on topic, “Recent Trends in Diabetes Research and Management” on 30^th November, 2016.
• Subject Expert for post of Pharmacist in Bihar Staff Selection Board, Patna, 2015.
• Member of Research Advisory Board, Mahavir Cancer Sansthan & Research Centre. Patna, Bihar.

• HIV
• Diabetes
• Cancer – working on Heavy Metals, Safety & Efficacy of drugs in monotherapy as well as combination therapy
• Survey Based KAP (Knowledge, Attitude, and Practice), QoL (Quality of Life) Studies of PKDL & HIV Patients.
• Pharmacovigilance
• Materiovigilance

1. Nikhil K, Kumar VU, Pandey K, Ravichandiran V, Murti K. Development and Validation of Knowledge Attitudes and Practices Questionnaire (Nu-KAPQ): for the assessment of Knowledge, Attitudes, and Practices Associated with Arsenic Biol Trace Elem Res. 2023 Nov 4. doi: 10.1007/s12011-023-03939-y. Epub ahead of print. PMID: 37924414.

2. Sachindra Kumar, Vishal Chhabra, Manmeet Mehra, Saranya K, Harish KumarB, Smita Shenoy, Ravindra Shantakumar Swamy, Krishna Murti, K. Sreedhara Ranganath Pai & Nitesh Kumar (2023) The fluorosis conundrum: bridging the gap between science and public health, Toxicology Mechanisms and Methods, DOI: 10.1080/15376516.2023.2268722.

3. Mounika VL, Kumar VU, Dhingra S, Ravichandiran V, Pandey K, Parihar VK, Murti K. CD4+ Count: a Variable to Be Considered to Prioritize COVID-19 Vaccination in PLHIV. Current Pharmacology Reports. 2023 Apr;9(2):90-7.

4. Shabil M, Kumar VU, Dhingra S, Ravichandiran V, Parihar VK, Kumar N, Pandey K, Murti K. Current Scenario and Strategies to Tackle Cardiovascular Disease Risk in HIV Geriatrics. Current Pharmacology Reports. 2023 Sep 5:1-7.

5. Sharma A, Singh A, Dar MA, Kaur RJ, Charan J, Iskandar K, Haque M, Murti K, Ravichandiran V, Dhingra S. Menace of antimicrobial resistance in LMICs: Current surveillance practices and control measures to tackle hostility. Journal of Infection and Public Health. 2022 Feb 1;15(2):172-81.

6. ARUN KUMAR, MD. SAMIUR RAHMAN, MOHAMMAD ALI, PASCAL SALAUN, ARTHUR GOURAIN, SURESH KUMAR, RANJIT KUMAR, PINTOO KUMAR NIRAJ, MUKESH KUMAR, DHRUV KUMAR, AKHOURI BISHWAPRIYA, SHREYA SINGH, KRISHNA MURTI, SAMEER DHINGRA, MAIKO SAKAMOTO, ASHOK KUMAR GHOSH, ASSESSMENT OF DISEASE BURDEN IN THE ARSENIC EXPOSED POPULATION OF CHAPAR VILLAGE OF SAMASTIPUR DISTRICT, BIHAR, INDIA, AND RELATED MITIGATION INITIATIVE. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH VOLUME 29, PAGES27443–27459 (2022)

7. SINGH A, RAMALINGAM P, DHINGRA S, RAVICHANDIRAN V, MURTI K. ARSENIC: A CULPABLE ELEMENT AND A POSSIBLE MENACE FOR HIV/AIDS PATIENTS. BIOLOGICAL TRACE ELEMENT RESEARCH. 2022 DEC;200(12):4955-66.

8. MEENAKSHI S, KUMAR VU, DHINGRA S, MURTI K. NASAL VACCINE AS A BOOSTER SHOT: A VIABLE SOLUTION TO RESTRICT PANDEMIC?. CLINICAL AND EXPERIMENTAL VACCINE RESEARCH. 2022 MAY;11(2):184.

9. DAR MA, CHAUHAN R, MURTI K, TRIVEDI V, DHINGRA S. DEVELOPMENT AND VALIDATION OF SUBJECTIVE FINANCIAL DISTRESS QUESTIONNAIRE (SFDQ): A PATIENT REPORTED OUTCOME MEASURE FOR ASSESSMENT OF FINANCIAL TOXICITY AMONG RADIATION ONCOLOGY PATIENTS. FRONTIERS IN ONCOLOGY. 2022 FEB 2;11:5922.

10. MADHU M, UDAYA KUMAR V, DHINGRA S, KUMAR N, SINGH S, RAVICHANDIRAN V, MURTI K. NUTRITIONAL ASPECTS OF PEOPLE LIVING WITH HIV (PLHIV) AMIDST COVID-19 PANDEMIC: AN INSIGHT. CURRENT PHARMACOLOGY REPORTS. 2022 OCT;8(5):350-64.

11. KUMAR VU, KT MF, SHARMA A, BISHT P, DHINGRA S, RAVICHANDIRAN V, RAMESH M, MURTI K. THE POSSIBLE ROLE OF SELECTED VITAMINS AND MINERALS IN THE THERAPEUTIC OUTCOMES OF LEISHMANIASIS. BIOLOGICAL TRACE ELEMENT RESEARCH. 2022 JUL 2:1-7.

12. KARUN A, KAUR RJ, CHARAN J, MURTI K, RAMESH M, RAVICHANDIRAN V, DHINGRA S. IMPACT OF COVID-19 ON ANTIMICROBIAL RESISTANCE IN PAEDIATRIC POPULATION: A NARRATIVE REVIEW. CURRENT PHARMACOLOGY REPORTS. 2022 OCT;8(5):365-75.

13. MEENAKSHI S, KUMAR VU, RAJU RS, DHINGRA S, KUMAR N, RAVICHANDIRAN V, MURTI K. AYURVEDA: THE PROMINENCE OF HERBAL MEDICINE IN CONTAINMENT OF COVID-19. PHARMACOGNOSY RESEARCH. 2022;14(3).

14. LINGAMAIAH D, NS S, MURTI K, SINGH S, RAVICHANDIRAN V, DHINGRA S. EMICIZUMAB: AN FDA-APPROVED MONOCLONAL ANTIBODY IN THE TREATMENT OF HEMOPHILIA A. CURRENT PHARMACOLOGY REPORTS. 2022 APR;8(2):121-9.

15. SHARMA A, KUMAR P, DUTTA S, KAUR RJ, CHARAN J, CHIKARA G, MURTI K, KUMARASAMY M, RAMESH M, PANDEY K, RAVICHANDIRAN V. PATHOPHYSIOLOGICAL AND GENETIC BASIS OF TENOFOVIR-INDUCED ACUTE RENAL DYSFUNCTION: STRATEGIES AND RECENT DEVELOPMENTS FOR BETTER CLINICAL OUTCOMES. CURRENT PHARMACOLOGY REPORTS. 2022 DEC;8(6):427-38.

16. DEVIPRIYA JS, GUPTA AK, PAVAN G, DHINGRA S, MURTI K, RAVICHANDIRAN V, PANDEY K. KNOWLEDGE, ATTITUDE, AND PRACTICES AMONG HIV/LEISHMANIASIS CO-INFECTED PATIENTS IN BIHAR, INDIA. THE AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE. 2022 AUG

17. KUMAR A, RAVI C, DHINGRA S, KRISHNA MURTI MA, GHOSH AK. ARSENIC CAUSING GALLBLADDER CANCER DISEASE NEAR THE HIMALAYAN BOUND RIVERS IN BIHAR: A CASE STUDY OF GALLBLADDER CANCER. JOURNAL OF CANCER SCIENCE AND CLINICAL THERAPEUTICS. 2022;6:388-91.

18. PADMAKAR S, MURTI K, PANDEY K, KUMARI S, KUMAR R, SIDDIQUI NA, PAL B. SUICIDAL IDEATION ASSOCIATED WITH VITILIGO-A SYSTEMATIC REVIEW OF PREVALENCE AND ASSESSMENT. CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH. 2022 SEP 11:101140.

19. DUBB S, KAUR G, KUMARI S, MURTI K, PAL B. COMPREHENSION AND COMPLIANCE WITH DISCHARGE INSTRUCTIONS AMONG PEDIATRIC CAREGIVERS. CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH. 2022 SEP 1;17:101137.

20. SAGAR S, BASHIR A, PAL B, DAR MA, PANDEY K, MURTI K. ASSESSMENT OF CONTRACEPTIVE UTILIZATION AND ASSOCIATED FACTORS AMONG SEXUALLY ACTIVE HIV-POSITIVE INDIAN WOMEN: A CROSS-SECTIONAL STUDY FROM AN ANTIRETROVIRAL THERAPY CENTER. CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH. 2021 APR 1;10:100682.

21. ANU M, XAVIER J, FATHIMA AS, BISHT P, MURTI K, RAVICHANDIRAN V, KUMAR N. EPIGENETIC BASIS FOR PARP MUTAGENESIS IN GLIOBLASTOMA: A REVIEW. EUROPEAN JOURNAL OF PHARMACOLOGY. 2022 NOV 26:175424.

22. SARITHA KELUTH, SRIKANTH JITTE, RASHMI BHUSHAN, OM PRAKASH RANJAN, KRISHNA MURTI, V. RAVICHANDIRAN, NITESH KUMAR. TARGETING ION CHANNELS FOR THE TREATMENT OF GLIOMA. MINI-REVIEWS IN MEDICINAL CHEMISTRY. BENTHAM PUBLISHER. NOVEMBER 2022. ISSN (PRINT): 1389-5575, ISSN (ONLINE): 1875-5607

23. JS D, Gupta AK, Veeri RB, Garapati P, Kumar R, Dhingra S, Murti K, Ravichandiran V, Pandey K. Knowledge, attitude and practices towards visceral leishmaniasis among HIV patients: A cross-sectional study from Bihar, India. Plos one. 2021 Aug 17;16(8):e0256239.

24. Pavan G, Murti K, Kumar R, Dhingra S, Haque M, Ravichandiran V. Rays of immunity: role of sunshine vitamin in management of COVID-19 infection and associated comorbidities. Clinical nutrition ESPEN. 2021 Dec 1;46:21-32.

25. Fathima AS, Mounika VL, Kumar VU, Gupta AK, Garapati P, Ravichandiran V, Dhingra S, Murti K. Mucormycosis: A triple burden in patients with diabetes during COVID-19 Pandemic. Health Sciences Review. 2021 Jan 1;1:100005.

26. Dar MA, Chauhan P, Kumar P, Chauhan R, Murti K, Charan J, Ravichandiran V, Dhingra S. Safety, efficacy, and immunogenicity of COVAXIN: A review. Journal of Applied Pharmaceutical Science. 2021 Oct 26;11(11):018-25.

27. Dar MA, Chauhan R, Sharma KK, Trivedi V, Dhingra S, Murti K. Assessing the reliability and validity of comprehensive score for financial toxicity (COST) among radiation oncology patients in India: a cross-sectional pilot study. ecancermedicalscience. 2021;15.

28. Bashir A, Azharuddin M, Rashid I, Murti K, Pandey K. Predictors of cardiomyopathy in patients with type-2 diabetes mellitus with and without cardiovascular complications: a cross-sectional study. Diabetes Research and Clinical Practice. 2019 Aug 1;154:90-100.

29. Bashir A, Pandey K, Azharuddin M, Kumari A, Rashid I, Siddiqui NA, Lal CS, Murti K. Association between diet quality scores, adiposity, glycemic status and nutritional biomarkers among Indian population with type 2 diabetes mellitus: A cross-sectional study. Clinical Epidemiology and Global Health. 2020 Mar 1;8(1):53-9.

30. Ali M, Ravichandiran V, Murti K, Pal B, Parwez A, Chauhan R, Trivedi V, Kumar R. Human Papilloma Virus Types 16/18 Distribution in Invasive Cervical Cancer: An Evidence for Vaccination in Bihar, India. Journal of Pharmaceutical Research International. 2021 Feb 9:59-68.

31. Choudhary KH, Garapati PA, Prasad SR, Murti KR, Singh SA, Kumar NI. COVID-19 vaccine hesitancy assessment among the educated Indian population: an online survey. Int j pharmaceutical res. 2021 Aug 2;13(03).